OvaScience to Present at the 35th Annual J.P. Morgan Healthcare Conference
January 05 2017 - 4:02PM
Business Wire
OvaScience℠ (NASDAQ: OVAS), a global fertility company focused
on the discovery, development and commercialization of new
treatment options, today announced that Michelle Dipp, M.D., Ph.D.,
Executive Chair and Co-founder of OvaScience, will present a
corporate overview at the 35th Annual J.P. Morgan Healthcare
Conference on Thursday, January 12, 2017 at 8:30 a.m. PT (11:30
a.m. ET) at the Westin St. Francis Hotel in San Francisco,
California.
A live audio webcast of the presentation can be accessed by
visiting the investor section of the company’s website at
www.ovascience.com. A replay of the webcast will be archived on the
OvaScience website for 30 days following the presentation.
About OvaScience℠OvaScience, Inc. (NASDAQ: OVAS) is a
global fertility company dedicated to improving treatment options
for women around the world. OvaScience is discovering, developing
and commercializing new fertility treatments because it believes
women deserve more options. Each OvaScience treatment is based on
the Company’s proprietary technology platform that leverages the
breakthrough discovery of egg precursor (EggPC℠) cells – immature
egg cells found inside the protective ovarian lining. OvaScience is
developing the OvaPrime℠ treatment, which could increase a woman’s
egg reserve, and the OvaTure℠ treatment, a potential
next-generation IVF treatment that could help a woman produce
healthy, young, fertilizable eggs without hormone injections.
OvaScience’s AUGMENT℠ treatment, a fertility option designed to
improve IVF success rates, is available in certain IVF clinics in
select international regions. OvaScience treatments are not
available in the U.S. For more information, visit
www.ovascience.com.
###
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170105006300/en/
OvaScienceJennifer Viera,
617-420-8748jviera@ovascience.com
Ovascience Inc. (delisted) (NASDAQ:OVAS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ovascience Inc. (delisted) (NASDAQ:OVAS)
Historical Stock Chart
From Apr 2023 to Apr 2024